Under the terms of the definitive agreement, Jemincare will be responsible for exclusive development and commercialisation of the Nafithromycin in the select markets, Wockhardt said added.from Moneycontrol Business News https://ift.tt/3kr2LcT
Thursday, August 26, 2021
Wockhardt, Jemincare partner for novel respiratory antibiotic Nafithromycin
Under the terms of the definitive agreement, Jemincare will be responsible for exclusive development and commercialisation of the Nafithromycin in the select markets, Wockhardt said added.from Moneycontrol Business News https://ift.tt/3kr2LcT
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment